# Actual cross-review with qualification_skeptic

Date: 2026-10-22. The independent assay draft was completed and communicated before reading the skeptic draft. SHA256 `4187c7e5250c2adee076a5e766375af863d31dce1b8e1ddfa063ca23405f1a75`; written seal was produced after exchange began and explicitly discloses that timing. Original draft remains unchanged. No supplementary numerical values or new data were read for this exchange.

## Reviewed material and received challenge

Read `log/20261022/decrypte_source_qualification/skeptic/INDEPENDENT.md` after writing my independent draft. The skeptic actually messaged two challenges:

1. My wording "An explicit row join is required" was too strict if interpreted as requiring same-well IDs. Authenticated drug x dose x background x protocol identity can support **condition-level** molecular/functional prediction without an individual sample correspondence.
2. My proposed effect-vs-noise signal qualification cannot be satisfied without functional repeats. It should restrict noise-normalized/reliability claims, rather than prohibit all numerical or descriptive prediction exploration.

## Response and accepted correction

Both challenges are accepted. A condition-level join is sufficient for its properly limited target. A same-well/sample mapping is needed only for claims of individual-state pairing, paired residuals, within-well coupling or paired-noise estimation. It is still necessary to verify identities, dose units, cell background and assay window; name similarity or many-to-many merging is not an authenticated condition join.

Missing independent functional repeats is an evidence limitation, not a proof that prediction is impossible. One can report observed normalized endpoint prediction with uncertainty about the decomposition into measurement noise and biological variation. One cannot use protein CV as functional noise, manufacture a 3x-noise criterion, or claim tiny improvements are biologically reliable without appropriate support. The original independent draft's requirement 3 should be interpreted as a qualification of the stronger signal/noise claims, alongside its explicitly allowed downgraded exploration in requirement 4.

## Questions sent back and actual reply

I challenged the skeptic's statement that items 1--3 were hard conditions: "per-well" and "definite join" should not inadvertently outlaw authenticated condition-level prediction. I also pointed out that all-dose fitted curves cause evaluation dependence even when they appear only as test targets, not just when they appear in the one-dose support set. A smoothed held-out target estimated using all five measurements is not an independent withheld observed dose.

The skeptic replied accepting both: the hard conditions apply to the proposed local-dose feedback contract, condition joins are sufficient for condition-level claims, and an all-dose fitted held-out target cannot be reported as an independent raw measurement prediction. This was an actual exchange via collaboration messages, not a hypothetical reconciliation.

## Resulting common disposition

- Continue source/header qualification. Raw or separately normalized per-dose function values would support a later frozen finite-dose feedback study, subject to task/reveal boundaries.
- Only a highest-dose summary stops **the low-budget feedback to unseen doses contract**. It does not rule out a separately preregistered highest-dose endpoint-prediction study or establish that cells lack response.
- Only all-dose fitted summaries similarly fail local-information budget claims; fitting ordinary models to the actual limited support could remain a legitimate baseline if raw data become available.
- Missing functional repeats limits noise identifiability and reliability evidence; it does not automatically veto descriptive model comparisons.
- Delayed 3/3.5h functional readout and distinct NFAT/primary-cell contracts must remain explicit.
- No new independent mechanism, biological performance, world-model contribution, agent contribution, inheritance or RSI result has been shown. Prior novelty STOPs stand.

No material unresolved reviewer disagreement remains on these source-only contract questions. Workbook availability and contents remain empirical unknowns for the root source-qualification work.
